Retrospective Evaluation of the Application of Dutasteride, Unapproved by the FDA, for Male Pattern Baldness in Korea
September 2015
in “
한국임상약학회지
”
TLDR The document's conclusion cannot be determined without content.
Related Community Posts Join
6 / 1000+ resultscommunity Why is everyone not directly advised Dutasteride?
Dutasteride is less commonly prescribed for hair loss because it is not FDA-approved for this purpose, unlike finasteride, which is more accessible and preferred due to fewer side effects. Dutasteride may be more effective in reducing DHT but has a longer half-life and potentially more significant side effects.
community When you pop your first Fin pill
Hair loss treatment using Fin, Minoxidil and RU58841 with discussion about potential side effects and the power of nocebo effect.
community 2021 Vs 2023, min + keto 2%. Added FIN + .5 Dermaroller March 2023
A user's progress pictures that show the results of their hair loss treatments, such as minoxidil and finasteride, along with dermarolling and clippers. They have been trying to recover from severe hair loss since 2021.
community Study of thousands of Fin users over 20 years finds no evidence of Fin induced sexual dysfunction
The conversation is about a finding that finasteride does not significantly increase the risk of sexual dysfunction, with users sharing mixed personal experiences regarding side effects.
community We need to keep these snake oil companies accountable.
Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.
community COMPLETE OVERVIEW of the Treatment of androgenetic alopecia in men
Male androgenetic alopecia is commonly treated with topical minoxidil and oral finasteride, both requiring continuous use. Other options include hair restoration surgery, dutasteride, light therapy, and camouflaging agents.
Similar Research
6 / 1000+ results
research Drug Discovery for Alopecia: Gone Today, Hair Tomorrow
Topical drugs and near-infrared light therapy show potential for treating alopecia.
research Status of Research on the Development and Regeneration of Hair Follicles
New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.
research The Hormonal Background of Hair Loss in Non-Scarring Alopecias
Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.
research The Childbearing Years: Hair Diseases
Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.
research A 25-Year-Old Man with Androgenetic Alopecia Developed Symptoms of Post-Finasteride Syndrome After Treatment with Finasteride and Dutasteride
Man experienced post-finasteride syndrome symptoms after using finasteride and dutasteride for hair loss.
research Evaluating 5 Alpha Reductase Inhibitors for the Treatment of Male Androgenic Alopecia
Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.